Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2011; 17(40): 4503-4508
Published online Oct 28, 2011. doi: 10.3748/wjg.v17.i40.4503
Table 1 Main clinical, laboratory and ultrasound characteristics of the patients included in the study (n = 35)
Overall(n = 35)Outpatients(n = 30)Hospitalized(n = 5)
Age (yr)50 ± 2050 ± 1751 ± 29
Gender (M/F)2/331/291/4
SLE duration (yr)6.9 ± 7.06.5 ± 6.69.6 ± 9.8
LAC positivity8/357/301/5
SLEDAI18.9 ± 4.29.1 ± 4.37.6 ± 2.8
ACR/SLICC12.1 ± 1.62.1 ± 1.72.2 ± 1.3
Acrocyanosis124/3318/284/5
Steroid treatment126/3322/284/5
Duration of steroid therapy (yr)16.4 ± 6.35.9 ± 5.79.5 ± 9.4
AST (U/L)22 ± 920 ± 534 ± 18
ALT (U/L)22 ± 918 ± 824 ± 13
Bilirubin (mg/dL)0.6 ± 0.40.5 ± 0.21.1 ± 0.8
GGT (U/L)32 ± 4022 ± 2067 ± 72
ALP (U/L)190 ± 105171 ± 78247 ± 159
Thrombosis of hepatic veins101
Normal liver echopattern981
NRH202
Single hepatic hemangioma1293
Multiple hepatic hemangioma770
Atypical hemangioma523
FNH220